OBJECT: Neurointensivists are specialists trained to manage all aspects of the intensive care unit (ICU) stay of neurologically ill patients. No study to date has examined the role of neurointensivists specifically in subarachnoid hemorrhage (SAH) management. This study examined the use of a team-based neurointensivist co-management approach. METHODS: The authors reviewed all cases involving patients with SAH admitted to the neurosurgical service during a period of more than 4 years. A comparison was made between those patients admitted before and those admitted after the initiation of a mandatory neurointensivist co-management strategy. The primary outcome examined was length of ICU stay. Secondary outcomes included in-hospital mortality, ventriculoperitoneal shunt placement, and other complications such as fever, antibiotic use, pressor utilization, and ventilator-associated pneumonia. RESULTS: A total of 512 patients were included, 216 prior to and 296 after the initiation of neurointensivist comanagement. Length of ICU stay was significantly decreased after the initiation of neurointensivist co-management (mean 12.4 vs 10.9 days, p = 0.02), even after adjusting for demographic characteristics and admission Hunt and Hess grade. The percentage of patients requiring a ventriculoperitoneal shunt significantly decreased after initiation of the co-management approach (23.0 vs 11.5%, p = 0.001), but in-house mortality was unaffected. CONCLUSIONS: Initiation of a strategy of routine involvement of a neurointensivist, charged with managing all aspects of the patients' care, resulted in a significantly reduced length of ICU stay for neurosurgical SAH patients. This team-based approach, using neurointensivists to manage neurosurgical SAH patients, merits further study as a successful model of care.
OBJECT: Neurointensivists are specialists trained to manage all aspects of the intensive care unit (ICU) stay of neurologically ill patients. No study to date has examined the role of neurointensivists specifically in subarachnoid hemorrhage (SAH) management. This study examined the use of a team-based neurointensivist co-management approach. METHODS: The authors reviewed all cases involving patients with SAH admitted to the neurosurgical service during a period of more than 4 years. A comparison was made between those patients admitted before and those admitted after the initiation of a mandatory neurointensivist co-management strategy. The primary outcome examined was length of ICU stay. Secondary outcomes included in-hospital mortality, ventriculoperitoneal shunt placement, and other complications such as fever, antibiotic use, pressor utilization, and ventilator-associated pneumonia. RESULTS: A total of 512 patients were included, 216 prior to and 296 after the initiation of neurointensivist comanagement. Length of ICU stay was significantly decreased after the initiation of neurointensivist co-management (mean 12.4 vs 10.9 days, p = 0.02), even after adjusting for demographic characteristics and admission Hunt and Hess grade. The percentage of patients requiring a ventriculoperitoneal shunt significantly decreased after initiation of the co-management approach (23.0 vs 11.5%, p = 0.001), but in-house mortality was unaffected. CONCLUSIONS: Initiation of a strategy of routine involvement of a neurointensivist, charged with managing all aspects of the patients' care, resulted in a significantly reduced length of ICU stay for neurosurgical SAHpatients. This team-based approach, using neurointensivists to manage neurosurgical SAHpatients, merits further study as a successful model of care.
Authors: Joey D English; Dileep R Yavagal; Rishi Gupta; Vallabh Janardhan; Osama O Zaidat; Andrew R Xavier; Raul G Nogueira; Jawad F Kirmani; Tudor G Jovin Journal: Interv Neurol Date: 2016-02-19
Authors: Josef M Lang; Jürgen Meixensberger; Andreas W Unterberg; Andreas Tecklenburg; Joachim K Krauss Journal: Langenbecks Arch Surg Date: 2011-03-08 Impact factor: 3.445
Authors: Emir Festic; Alejandro A Rabinstein; William D Freeman; Elizabeth A Mauricio; Maisha T Robinson; Jay Mandrekar; Abba C Zubair; Augustine S Lee; Ognjen Gajic Journal: Neurocrit Care Date: 2013-04 Impact factor: 3.210
Authors: Pieter M Cobelens; Ivo A C W Tiebosch; Rick M Dijkhuizen; Peter H van der Meide; René Zwartbol; Cobi J Heijnen; Jozef Kesecioglu; Walter M van den Bergh Journal: Crit Care Date: 2010-08-23 Impact factor: 9.097